Showing results (81-90 of 217) with videos related to

Sort By:
Pageof 22
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 1, 2017
Prospective Evaluation of 68Ga-RM2 PET/MRI in Patients with Biochemical Recurrence of Prostate Cancer and Negative Findings on Conventional ImagingRyogo Minamimoto, Ida Sonni, Steven Hancock, et al.
Clinical Nuclear Medicine|April 19, 2017
Initial Experience With Simultaneous 18F-FDG PET/MRI in the Evaluation of Cardiac Sarcoidosis and MyocarditisKate Hanneman, Michael Kadoch, Henry H Guo, et al.
Translational Oncology|November 25, 2021
68Ga-PSMA11 PET/CT for biochemically recurrent prostate cancer: Influence of dual-time and PMT- vs SiPM-based detectorsHeying Duan, Lucia Baratto, Negin Hatami, et al.
Plos One|June 6, 2017
18F-FDG silicon photomultiplier PET/CT: A pilot study comparing semi-quantitative measurements with standard PET/CTLucia Baratto, Sonya Young Park, Negin Hatami, et al.
Hellenic Journal of Nuclear Medicine|December 17, 2008
(18)F-FDG-PET/CT evaluation of response to treatment in lymphoma: when is the optimal time for the first re-evaluation scan?Andrei Iagaru, Yingbing Wang, Carina Mari, et al.
Nuclear Medicine Communications|October 30, 2015
Evaluation of a new motion correction algorithm in PET/CT: combining the entire acquired PET data to create a single three-dimensional motion-corrected PET/CT imageRyogo Minamimoto, Takuya Mitsumoto, Yoko Miyata, et al.
Diagnostics (Basel, Switzerland)|June 2, 2021
Results of a Prospective Trial to Compare 68Ga-DOTA-TATE with SiPM-Based PET/CT vs. Conventional PET/CT in Patients with Neuroendocrine TumorsLucia Baratto, Akira Toriihara, Negin Hatami, et al.
AJR. American Journal of Roentgenology|August 18, 2021
Reduced Acquisition Time per Bed Position for PET/MRI Using 68Ga-RM2 or 68Ga-PSMA-11 in Patients With Prostate Cancer: A Retrospective AnalysisHeying Duan, Lucia Baratto, Negin Hatami, et al.
European Journal of Nuclear Medicine and Molecular Imaging|July 28, 2019
Prognostic value of somatostatin receptor expressing tumor volume calculated from 68Ga-DOTATATE PET/CT in patients with well-differentiated neuroendocrine tumorsAkira Toriihara, Lucia Baratto, Tomomi Nobashi, et al.
Radiology|July 18, 2014
(18)F-FPPRGD2 PET/CT: pilot phase evaluation of breast cancer patientsAndrei Iagaru, Camila Mosci, Bin Shen, et al.
Pageof 22